Search

Your search keyword '"Naito, Tateaki"' showing total 887 results

Search Constraints

Start Over You searched for: Author "Naito, Tateaki" Remove constraint Author: "Naito, Tateaki"
887 results on '"Naito, Tateaki"'

Search Results

1. The efficacy and safety of anamorelin among patients with diabetes

4. Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing

5. Effect of polypharmacy on the outcomes of older patients with advanced non-small-cell lung cancer treated with PD-1/PD-L1 inhibitors: A retrospective cohort study

12. Correction to: First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1

16. Long-term survival data of patients with limited disease small cell lung cancer: a retrospective analysis

21. Exploring the relationship between anorexia and therapeutic efficacy in advanced lung cancer treatment: a retrospective study.

22. Prognostic Impact of Postoperative Recurrence in Patients With Epidermal Growth Factor Receptor–Positive Non‐Small Cell Lung Cancer.

24. Exploring the Relationship Between Anorexia and Therapeutic Efficacy in Advanced Lung Cancer Treatment: A Retrospective Study

27. Clinical impact of walking capacity on the risk of disability and hospitalizations among elderly patients with advanced lung cancer

28. Retrospective analysis of osimertinib re-challenge after osimertinib-induced interstitial lung disease in patients with EGFR-mutant non-small cell lung carcinoma

29. Detection of programmed cell death-ligand 1 using 22C3 antibody in patients with unresectable stage III non-small cell lung cancer receiving chemoradiotherapy

30. Suitability of frozen cell pellets from cytology specimens for the Amoy 9‐in‐1 assay in patients with non‐small cell lung cancer.

32. Relationship between patterns of immunohistochemical conventional neuroendocrine markers and efficacy of immune check point inhibitors in patients with extensive disease small cell lung cancer

34. The barriers to interprofessional care for cancer cachexia among Japanese healthcare providers: A nationwide survey

35. Prognostic impact of postoperative recurrence in patients with epidermal growth factor receptor-positive non-small cell lung cancer.

38. Association between oligo-residual disease and patterns of failure during EGFR-TKI treatment in EGFR-mutated non-small cell lung cancer: a retrospective study

40. Clinical and radiation dose-volume factors related to pneumonitis after treatment with radiation and durvalumab in locally advanced non-small cell lung cancer

44. Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-Mutant Non-Small Cell Lung Cancer With Brain Metastases Stratified by Number of Brain Metastases

47. Safety and efficacy of amrubicin with primary prophylactic pegfilgrastim as second‐line chemotherapy in patients with small cell lung cancer

48. Diagnosis and outcomes of cachexia in Asia: Working Consensus Report from the Asian Working Group for Cachexia

49. Concordance of ALK fusion gene-rearrangement between immunohistochemistry and next-generation sequencing

Catalog

Books, media, physical & digital resources